Russell Investments Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.72M Buy
171,395
+29,642
+21% +$643K ﹤0.01% 1391
2025
Q1
$3.44M Sell
141,753
-34,506
-20% -$837K ﹤0.01% 1387
2024
Q4
$3.68M Buy
176,259
+2,471
+1% +$51.6K 0.01% 1324
2024
Q3
$3.45M Sell
173,788
-41,749
-19% -$830K 0.01% 1387
2024
Q2
$3.34M Sell
215,537
-22,207
-9% -$344K 0.01% 1362
2024
Q1
$3.79M Buy
237,744
+45,863
+24% +$731K 0.01% 1292
2023
Q4
$3.23M Buy
191,881
+10,013
+6% +$168K 0.01% 1356
2023
Q3
$2.13M Sell
181,868
-14,522
-7% -$170K ﹤0.01% 1513
2023
Q2
$2.64M Sell
196,390
-166,127
-46% -$2.23M 0.01% 1408
2023
Q1
$6.01M Buy
362,517
+86,231
+31% +$1.43M 0.01% 1024
2022
Q4
$5.14M Sell
276,286
-19,334
-7% -$360K 0.01% 1084
2022
Q3
$3.79M Sell
295,620
-143,061
-33% -$1.84M 0.01% 1199
2022
Q2
$3.07M Buy
438,681
+35,066
+9% +$246K 0.01% 1352
2022
Q1
$3.34M Sell
403,615
-64,607
-14% -$535K 0.01% 1371
2021
Q4
$3.17M Buy
468,222
+19,086
+4% +$129K 0.01% 1532
2021
Q3
$2.38M Sell
449,136
-35,003
-7% -$185K ﹤0.01% 1727
2021
Q2
$2.78M Sell
484,139
-176,036
-27% -$1.01M ﹤0.01% 1718
2021
Q1
$3.04M Buy
660,175
+214,455
+48% +$988K 0.01% 1631
2020
Q4
$1.49M Buy
445,720
+38,077
+9% +$127K ﹤0.01% 1912
2020
Q3
$1.21M Buy
407,643
+94,586
+30% +$281K ﹤0.01% 1975
2020
Q2
$1.44M Sell
313,057
-6,928
-2% -$31.9K ﹤0.01% 1836
2020
Q1
$1.23M Buy
319,985
+80,329
+34% +$309K ﹤0.01% 1744
2019
Q4
$896K Buy
+239,656
New +$896K ﹤0.01% 2156
2018
Q4
Sell
-3,264
Closed -$12K 2934
2018
Q3
$12K Sell
3,264
-9,723
-75% -$35.7K ﹤0.01% 2921
2018
Q2
$41K Sell
12,987
-3,908
-23% -$12.3K ﹤0.01% 2832
2018
Q1
$40K Hold
16,895
﹤0.01% 2843
2017
Q4
$68K Sell
16,895
-801
-5% -$3.22K ﹤0.01% 2836
2017
Q3
$44K Hold
17,696
﹤0.01% 2866
2017
Q2
$49K Buy
+17,696
New +$49K ﹤0.01% 2881